e-Drug3D

22

METHAMPHETAMINE


INN
METHAMPHETAMINE

(is an active metabolite) (has an active metabolite)

cas 537-46-2
CLASS

NERVOUS SYSTEM
SYMPATHOMIMETIC AMINE
PSYCHOSTIMULANTS
TREATMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
TREATMENT OF EXOGENOUS OBESITY
LEADS TO THE FORMATION OF REACTIVE OXYGEN SPECIES IN THE BRAIN

ROUTE (list)

ORAL

NATURAL MOLECULE (link)

ATC code

N06BA03

PK parameters

F 67.2 PERCENT (PMID8104133)
VD 242 LITER (65 KILOGRAM)
Cl 17.1 LITER / HOUR (65 KILOGRAM)
PPB 15 PERCENT
t1/2 12.2 HOUR

Target

TARGET DOPAMINE TRANSPORTER (DAT)
SEROTONINE TRANSPORTER

PDB
4XP6 (X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE)

Ligand code = B40 (link to the list of PDB complexes)

Download experimental 3D coordinates of B40 with added hydrogens

DrugCentral

Sodium-dependent dopamine transporter UNIPROT Q01959 SLC6A3

Download SDF file (2S)-N-methyl-1-phenylpropan-2-amine

Formula:
C10H15N

Calculated chemical properties:

MW 149.23
NB_atoms 11
XLogP 1.84
PSA 12.207
NB_HD 1
NB_HA 1
fsp3 0.40
Lipinski(0=no;1=yes) 1

FDA
NDA 083889 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPEX (TEVA) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 086359 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPHETAMINE HYDROCHLORIDE (TEVA) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 005378 (label) INN (METHAMPHETAMINE HYDROCHLORIDE) DESOXYN (AJENAT PHARMS) APPROVAL= AP YEAR= 1943
NDA 084931 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPHETAMINE HYDROCHLORIDE (REXAR) APPROVAL= AP YEAR= 1976 DISCONTINUED
NDA 040529 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPHETAMINE HYDROCHLORIDE (ABLE) APPROVAL= AP YEAR= 2004 DISCONTINUED
NDA 091189 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPHETAMINE HYDROCHLORIDE (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2010
NDA 203846 (pdf not found) INN (METHAMPHETAMINE HYDROCHLORIDE) METHAMPHETAMINE HYDROCHLORIDE (HIKMA) APPROVAL= AP YEAR= 2015

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL